ACCILIV SACHET contains L-Ornithine L-Aspartate 3gm per sachet, designed specifically to support liver health and manage hepatic encephalopathy and other liver-related disorders. This proprietary formulation stimulates the urea cycle and glutamine synthesis to effectively reduce elevated ammonia levels in serum and cerebrospinal fluid, improving mental status in patients suffering from hepatic encephalopathy. Each pack contains 10 sachets of 5gm each, suitable for precise dosage administration. ACCILIV SACHET also supports tissue regeneration by saturating tissue ornithine concentration, thus preventing postprandial hyperammonemia. Clinical studies have demonstrated that ACCILIV SACHET enhances the quality of life for chronic liver disease patients, demonstrates superior effectiveness compared to placebo and glycyrrhizin, and reduces hospital stay duration in advanced hepatic encephalopathy cases. It is indicated for a broad spectrum of liver conditions including cirrhosis, jaundice, alcoholic liver disease, chronic hepatitis, hyperammonemia, wound healing, and as adjunct therapy in infections like malaria, typhoid, and tuberculosis. Recommended dosage is 1-2 sachets, three times daily, dissolved in a liquid or as prescribed by a healthcare professional.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | L-Ornithine L-Aspartate 3 gm per sachet |
| Pack Size | 10 packs x 1 unit x 5 gm sachets |
| Formulation Type | Sachet - powder/dissolvable form |
| Primary Indications | Hepatic Encephalopathy, Cirrhosis, Chronic Liver Disease, Hyperammonemia |
| Mechanism of Action | Stimulates urea cycle and glutamine synthesis to lower ammonia levels |
| Clinical Benefits | Improves mental status, reduces serum and spinal fluid ammonia, enhances quality of life |
| Dosage | 1-2 sachets three times a day, dissolved in liquid or as directed |
| Supporting Evidence | Backed by multiple clinical studies showing safety and efficacy |
| Additional Indications | Alcoholic Liver Disease, Jaundice, Wound Healing, Adjuvant for infections |
| Packaging and Pricing | MRP ₹1400 for 10 sachets |
| Attributes | Description |
|---|---|
| Brand | ACCILIV SACHET |
| Ingredient Composition | L-Ornithine L-Aspartate 3 gm |
| Packaging Type | Sachet |
| Quantity Per Pack | 10 sachets per box |
| Weight Per Sachet | 5 gm |
| Recommended Usage | Oral administration, dissolved in liquid |
| Therapeutic Area | Hepatology (Liver Health) |
| Shelf Life | Refer to packaging or manufacturer guidelines |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ACCILIV SACHET delivers L-Ornithine L-Aspartate which stimulates the urea cycle and glutamine synthesis, significantly reducing excess ammonia levels in the blood and cerebrospinal fluid, thereby improving mental status and symptoms associated with hepatic encephalopathy.
Yes, ACCILIV SACHET is indicated for both acute and chronic liver ailments including cirrhosis, chronic hepatitis, and post-hepatitis convalescence, helping in managing hyperammonemia and promoting liver tissue regeneration.
Clinical studies have demonstrated that ACCILIV SACHET is safe for use in patients with advanced hepatic encephalopathy, showing relatively rapid improvement and reduction in hospital stay duration.
The recommended dosage is 1 to 2 sachets taken three times daily, dissolved in a liquid medium or as directed by a physician.
Besides liver conditions, ACCILIV SACHET is useful as an adjuvant therapy in infections such as malaria, typhoid, and tuberculosis, supporting overall metabolic recovery.
Country Of Origin: India
BRAND : ACCILIV SACHET
INGREDIENTS: L-Ornithine- L-Aspartate 3gm
PACK SIZE: 10X1X5 GM
PACK TYPE: SACHET
MRP :1400 FOR 10 SACHETT
* Administration of L-ornithine L-aspartate (LOLA) improves mental status & decreases serum and spinal fluid ammonia levels by stimulating both the urea cycle and glutamine (Gin) synthesis. It is also superior to a placebo for management of Hepatic Encephalopathy (HE), and its effectiveness could be higher with the more severe grades of this syndrome.
* It is effective not only in reducing hyperammonemia and the severity of this disease, but also in improving the patient's perceived quality of life. Therefore, LOLA is a promising alternative for the management of HE. Hepatol. 2011 Jun: 10 Suppl 2.555-9,
* It saturates tissue ornithine concentration to prevent postprandial hyperam-monemia and to stimulate tissue regeneration. Pal Merkur Lekarski 2010 Jun 28(108) 490-5
* When compared with the compound glycyrrhizin, LOLA granules provided a better maintenance of resolved Gamma-GT level. Therefore, in treating chronic liver disease; the effect of LOLA appears to be more reliable and stable as well as safe for clinical use. Zhonghua Gan Zang Bing za zhi, 2014 Jul 22(7):525-8
* In cirrhotic patients with advanced hepatic encephalopathy treatment with LOLA was safe and associated with relatively rapid improvement & shorter hospital stay. I Coll Physicians Surg Pak. 2011 Nov 21/11):666-71
Indications:
*Cirrhosis
*Jaundice
*Wound Healing
*Loss of Appetite
*Hyperammonemia
*Chronic Liver Disease
*Alcoholic Liver Disease
*Hepatic Encephalopathy
Acute & Chronic Hepatitis
*Post Hepatitis Convalescence
*Toxic Metabolic Liver Damages
*Adjuvant Therapy in Malaria, Typhoid & Tuberculosis
Dosage: 1-2 sachets 3 times a day dissolved in liquid or as directed by the physician.
Inclusive of all taxes
You Save: 0
Jabalpur , India
Manufacturer, Brand Owner, Distributor, Exporter, Wholesaler, Startup
